Style | Citing Format |
---|---|
MLA | Fardesfahani A, et al.. "Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer." Iranian Journal of Nuclear Medicine, vol. 28, no. 1, 2020, pp. 14-20. |
APA | Fardesfahani A, Valipouri MR, Harsini S, Beiki D, Emamiardekani A, Fallahi B, Eftekhari M (2020). Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer. Iranian Journal of Nuclear Medicine, 28(1), 14-20. |
Chicago | Fardesfahani A, Valipouri MR, Harsini S, Beiki D, Emamiardekani A, Fallahi B, Eftekhari M. "Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer." Iranian Journal of Nuclear Medicine 28, no. 1 (2020): 14-20. |
Harvard | Fardesfahani A et al. (2020) 'Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer', Iranian Journal of Nuclear Medicine, 28(1), pp. 14-20. |
Vancouver | Fardesfahani A, Valipouri MR, Harsini S, Beiki D, Emamiardekani A, Fallahi B, et al.. Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer. Iranian Journal of Nuclear Medicine. 2020;28(1):14-20. |
BibTex | @article{ author = {Fardesfahani A and Valipouri MR and Harsini S and Beiki D and Emamiardekani A and Fallahi B and Eftekhari M}, title = {Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer}, journal = {Iranian Journal of Nuclear Medicine}, volume = {28}, number = {1}, pages = {14-20}, year = {2020} } |
RIS | TY - JOUR AU - Fardesfahani A AU - Valipouri MR AU - Harsini S AU - Beiki D AU - Emamiardekani A AU - Fallahi B AU - Eftekhari M TI - Predictors of Success of the Ablative/Therapeutic Radioiodine (131I) in Differentiated Thyroid Cancer JO - Iranian Journal of Nuclear Medicine VL - 28 IS - 1 SP - 14 EP - 20 PY - 2020 ER - |